The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
Throughout October, we will be recognising Breast Cancer Awareness Month. Our scientists have been involved in some of the most famous discoveries in breast cancer research, leading studies that have transformed treatment for breast cancer on a global scale.
Olympic gold medallist Greg Rutherford MBE and Paralympic gold medallist Erin Kennedy MBE have launched an inspirational run which will see 'FINISH CANCER' imprinted in the sands of the British coastline.
A new study has provided insights into an important biological mechanism that supports survival of aggressive, hard-to-treat cancers – and in the process, uncovered fascinating new information about how cells divide and grow.
We aim to attract the best scientific minds who will be working at the forefront of cancer research, in an environment that’s collaborative, international and inclusive.
We are internationally renowned for driving scientific discoveries on cancer and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
Our competitive PhD programme is designed for the next generation of world-leading cancer researchers who will benefit from exceptional research facilities.
Our research is made possible by our generous community of donors and supporters. Help transform the lives of people with cancer.
We draw upon our excellent scientists and facilities to further our world-class cancer research. We work with funders to deliver major research centres and collaborations.
Help give more patients the hope of a cure with immunotherapy – with your support, we can discover even more of immunotherapy’s potential.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.
The ICR-CTSU leads high-quality international cancer clinical trials, and their findings directly influence clinical practice within the NHS and worldwide.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
Our changing approach to rare cancers is driving progress, but we still have further to go
‘The role of advocacy is extremely important’ – improving treatment for the childhood cancer neuroblastoma